Clinical Trial Update: Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin Malignancies [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update evaluating RP1 in adults with organ transplants and advanced skin cancers, including Merkel cell carcinoma, basal cell carcino…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma
• Cutaneous Squamous Cell Carcinoma
• Merkel Cell Carcinoma

Drugs mentioned

• RP1

Snippet

Sponsor: Replimune, Inc. | Conditions: Merkel Cell Carcinoma, Basal Cell Carcinoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING